Literature DB >> 3114243

Verapamil: a new antimanic drug with potential interactions with lithium.

S L Dubovsky, R D Franks, S Allen.   

Abstract

Verapamil is a calcium channel blocking agent with possible antimanic properties. In two elderly manic patients taking the medication in combination with lithium carbonate, profound bradycardia developed and was followed by a fatal myocardial infarction in one case. Clinical implications and possible mechanisms of cardiovascular interactions between verapamil and lithium are discussed. Caution is advised in the use of lithium and verapamil together.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3114243

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  9 in total

Review 1.  Do calcium antagonists have a place in the treatment of mood disorders?

Authors:  C Höschl
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 2.  Pharmacokinetic interactions with calcium channel antagonists (Part II).

Authors:  K D Schlanz; S A Myre; M B Bottorff
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 3.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 4.  Assessment and treatment of bipolar disorder in the elderly.

Authors:  J H Eastham; D V Jeste; R C Young
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

5.  Comparative study of electrocardiographic changes in patients of acute mania receiving verapamil or lithium carbonate.

Authors:  Mukhtiar Singh; Sharanjit Kaur; Vijay Kumar Sehgal
Journal:  J Clin Diagn Res       Date:  2014-12-05

6.  Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.

Authors:  Alan G Mallinger; Michael E Thase; Roger Haskett; Joan Buttenfield; David A Luckenbaugh; Ellen Frank; David J Kupfer; Husseini K Manji
Journal:  Bipolar Disord       Date:  2008-12       Impact factor: 6.744

Review 7.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 8.  Drug Interactions with Lithium: An Update.

Authors:  Patrick R Finley
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

Review 9.  A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

Authors:  A Cipriani; K Saunders; M-J Attenburrow; J Stefaniak; P Panchal; S Stockton; T A Lane; E M Tunbridge; J R Geddes; P J Harrison
Journal:  Mol Psychiatry       Date:  2016-05-31       Impact factor: 15.992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.